These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2434032)

  • 1. Serum samples from patients with active psoriasis enhance lymphocyte-induced angiogenesis and modulate endothelial cell proliferation.
    Majewski S; Tigalonowa M; Jabłónska S; Polakowski I; Janczura E
    Arch Dermatol; 1987 Feb; 123(2):221-5. PubMed ID: 2434032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic capability of peripheral blood mononuclear cells in psoriasis.
    Majewski S; Kamiński M; Jabłońska S; Szmurło A; Pawińska M
    Arch Dermatol; 1985 Aug; 121(8):1018-21. PubMed ID: 2411227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of psoriatic patients' neutrophils and sera on angiogenic capability and natural cytotoxicity of normal human peripheral blood mononuclear cells.
    Majewski S; Wasik M; Jabłońska S; Tigałonowa M; Langner A
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):465-70. PubMed ID: 2484151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adhesion of peripheral blood mononuclear cells and CD4+ T cells from patients with psoriasis to cultured endothelial cells via the interaction between lymphocyte function-associated antigen type 1 and intercellular adhesion molecule 1.
    Watabe D; Kanno H; Yoshida A; Kurose A; Akasaka T; Sawai T
    Br J Dermatol; 2007 Aug; 157(2):259-65. PubMed ID: 17596165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased endothelemia as an indirect marker of changes in the blood vessel endothelium in psoriasis.
    Sochorova R; Svecova D; Sinka L; Rybarova L
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):556-9. PubMed ID: 15324392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis.
    Henno A; Blacher S; Lambert C; Colige A; Seidel L; Noël A; Lapière C; de la Brassinne M; Nusgens BV
    Br J Dermatol; 2009 Mar; 160(3):581-90. PubMed ID: 18945297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo.
    McNamara DA; Harmey J; Wang JH; Kay E; Walsh TN; Bouchier-Hayes DJ
    Eur J Surg Oncol; 2001 Dec; 27(8):714-8. PubMed ID: 11735166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of systemic etretinate treatment on natural cytotoxicity, immune angiogenesis and neutrophil adherence in patients with various forms of psoriasis.
    Majewski S; Wolska H; Jabłońska S; Wasik M
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):459-64. PubMed ID: 2484150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis in normal and psoriatic skin.
    Wolf JE
    Lab Invest; 1989 Aug; 61(2):139-42. PubMed ID: 2474088
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
    Markham T; Mullan R; Golden-Mason L; Rogers S; Bresnihan B; Fitzgerald O; Fearon U; Veale DJ
    J Am Acad Dermatol; 2006 Jun; 54(6):1003-12. PubMed ID: 16713454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis.
    Malhotra R; Stenn KS; Fernandez LA; Braverman IM
    Lab Invest; 1989 Aug; 61(2):162-5. PubMed ID: 2474089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
    Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
    Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UVB therapy decreases the adhesive interaction between peripheral blood mononuclear cells and dermal microvascular endothelium, and regulates the differential expression of CD54, VCAM-1, and E-selectin in psoriatic plaques.
    Cai JP; Harris K; Falanga V; Taylor JR; Chin YH
    Br J Dermatol; 1996 Jan; 134(1):7-16. PubMed ID: 8745879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis.
    Creamer D; Allen MH; Sousa A; Poston R; Barker JN
    Br J Dermatol; 1997 Jun; 136(6):859-65. PubMed ID: 9217817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Streptococcus pyogenes and skin autoantigens in guttate psoriasis.
    Villeda-Gabriel G; Santamaría-Cogollos LC; Pérez-Lorenzo R; Reyes-Maldonado E; Saúl A; Jurado-Santacruz F; Jiménez-Zamudio L; García-Latorre E
    Arch Med Res; 1998; 29(2):143-8. PubMed ID: 9650329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of the angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase in psoriatic epidermis.
    Creamer D; Jaggar R; Allen M; Bicknell R; Barker J
    Br J Dermatol; 1997 Dec; 137(6):851-5. PubMed ID: 9470899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.
    Balsari A; Maier JA; Colnaghi MI; Ménard S
    Lab Invest; 1999 Jul; 79(7):897-902. PubMed ID: 10418830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
    Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
    Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.